375 related articles for article (PubMed ID: 8805247)
41. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.
Weinzierl AO; Rudolf D; Hillen N; Tenzer S; van Endert P; Schild H; Rammensee HG; Stevanović S
Eur J Immunol; 2008 Jun; 38(6):1503-10. PubMed ID: 18446792
[TBL] [Abstract][Full Text] [Related]
42. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences.
Lee N; Goodlett DR; Ishitani A; Marquardt H; Geraghty DE
J Immunol; 1998 May; 160(10):4951-60. PubMed ID: 9590243
[TBL] [Abstract][Full Text] [Related]
43. HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies.
Ravindranath MH; Taniguchi M; Chen CW; Ozawa M; Kaneku H; El-Awar N; Cai J; Terasaki PI
Mol Immunol; 2010 Feb; 47(5):1121-31. PubMed ID: 19944464
[TBL] [Abstract][Full Text] [Related]
44. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis.
Zappacosta F; Borrego F; Brooks AG; Parker KC; Coligan JE
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6313-8. PubMed ID: 9177214
[TBL] [Abstract][Full Text] [Related]
45. Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the cell surface in the context of HLA-E.
Millo E; Pietra G; Armirotti A; Vacca P; Mingari MC; Moretta L; Damonte G
J Immunol Methods; 2007 Apr; 322(1-2):128-36. PubMed ID: 17331531
[TBL] [Abstract][Full Text] [Related]
46. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
Ueno T; Tomiyama H; Takiguchi M
J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
[TBL] [Abstract][Full Text] [Related]
47. HLA Class I protein expression in the human placenta.
Blaschitz A; Hutter H; Dohr G
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
[TBL] [Abstract][Full Text] [Related]
48. Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.
Hogan KT; Shimojo N; Walk SF; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
J Exp Med; 1988 Aug; 168(2):725-36. PubMed ID: 3261776
[TBL] [Abstract][Full Text] [Related]
49. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules.
Menier C; Saez B; Horejsi V; Martinozzi S; Krawice-Radanne I; Bruel S; Le Danff C; Reboul M; Hilgert I; Rabreau M; Larrad ML; Pla M; Carosella ED; Rouas-Freiss N
Hum Immunol; 2003 Mar; 64(3):315-26. PubMed ID: 12590976
[TBL] [Abstract][Full Text] [Related]
50. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.
Agrawal S; Pandey MK
J Hematother Stem Cell Res; 2003 Dec; 12(6):749-56. PubMed ID: 14977483
[TBL] [Abstract][Full Text] [Related]
51. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells.
Chumbley G; King A; Robertson K; Holmes N; Loke YW
Cell Immunol; 1994 May; 155(2):312-22. PubMed ID: 8181068
[TBL] [Abstract][Full Text] [Related]
52. Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents.
Sernee MF; Ploegh HL; Schust DJ
Mol Immunol; 1998 Feb; 35(3):177-88. PubMed ID: 9694518
[TBL] [Abstract][Full Text] [Related]
53. Antigen-presenting function of the TL antigen and mouse CD1 molecules.
Cheroutre H; Holcombe HR; Tangri S; Castaño AR; Teitell M; Miller JE; Cardell S; Benoist C; Mathis D; Huse WD
Immunol Rev; 1995 Oct; 147():31-52. PubMed ID: 8847078
[TBL] [Abstract][Full Text] [Related]
54. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells.
Pazmany L; Mandelboim O; Valés-Gómez M; Davis DM; Reyburn HT; Strominger JL
Science; 1996 Nov; 274(5288):792-5. PubMed ID: 8864122
[TBL] [Abstract][Full Text] [Related]
55. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.
Jun Y; Kim E; Jin M; Sung HC; Han H; Geraghty DE; Ahn K
J Immunol; 2000 Jan; 164(2):805-11. PubMed ID: 10623826
[TBL] [Abstract][Full Text] [Related]
56. The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.
Sala FG; Del Moral PM; Pizzato N; Legrand-Abravanel F; Le Bouteiller P; Lenfant F
Immunogenetics; 2004 Dec; 56(9):617-24. PubMed ID: 15578261
[TBL] [Abstract][Full Text] [Related]
57. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells.
Allan DS; Colonna M; Lanier LL; Churakova TD; Abrams JS; Ellis SA; McMichael AJ; Braud VM
J Exp Med; 1999 Apr; 189(7):1149-56. PubMed ID: 10190906
[TBL] [Abstract][Full Text] [Related]
58. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.
Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI
Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594
[TBL] [Abstract][Full Text] [Related]
59. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.
Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
J Exp Med; 1993 Oct; 178(4):1321-36. PubMed ID: 8376937
[TBL] [Abstract][Full Text] [Related]
60. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).
Shiroishi M; Kuroki K; Rasubala L; Tsumoto K; Kumagai I; Kurimoto E; Kato K; Kohda D; Maenaka K
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16412-7. PubMed ID: 17056715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
